These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8766945)

  • 61. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
    Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complex effects of apoplexy secondary to pituitary adenoma.
    Zhang RC; Mu YF; Dong J; Lin XQ; Geng DQ
    Rev Neurosci; 2017 Jan; 28(1):59-64. PubMed ID: 27802176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
    Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bromocriptine, a dopamine agonist, increases growth hormone secretion in a patient with acromegaly.
    Arihara Z; Sakurai K; Yamashita R; Niitsuma S; Ueno T; Yamamura N; Yamada S; Inoshita N; Takahashi K
    Tohoku J Exp Med; 2014 Oct; 234(2):129-35. PubMed ID: 25253414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis and management of acromegaly: giant invasive adenoma.
    Cahyanur R; Setyawan W; Sudrajat DG; Setyowati S; Purnamasari D; Soewondo P
    Acta Med Indones; 2011 Apr; 43(2):122-8. PubMed ID: 21785175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
    Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
    Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
    Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
    J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Are there alternative tests for diagnosis of acromegaly?
    Popovic V
    J Endocrinol Invest; 2005; 28(11 Suppl International):73-4. PubMed ID: 16625850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adenoma size and postoperative IGF-1 levels predict surgical outcomes in acromegaly patients: results of the Swiss Pituitary Registry (SwissPit).
    Kempf J; Schmitz A; Meier A; Delfs N; Mueller B; Fandino J; Schuetz P; Berkmann S
    Swiss Med Wkly; 2018 Aug; 148():w14653. PubMed ID: 30141524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Cognition disorder (recurrent symptoms) and acromegalic facies: acromegaly and pituitary apoplexy].
    Enomoto K; Inoue K; Enomoto N; Irie M
    Nihon Rinsho; 1975 Apr; Spec No():924-5, 1404-5. PubMed ID: 1240425
    [No Abstract]   [Full Text] [Related]  

  • 76. [A case of GH and TSH secreting pituitary macroadenoma].
    Gołkowski F; Buziak-Bereza M; Stefańska A; Trofimiuk M; Pantofliński J; Huszno B; Czepko R; Adamek D
    Przegl Lek; 2006; 63(2):106-8. PubMed ID: 16967720
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
    Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
    Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin-mediated "pseudoacromegaly".
    Sam AH; Tan T; Meeran K
    Hormones (Athens); 2011; 10(2):156-61. PubMed ID: 21724541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy.
    Sanz-Sapera E; Sarria-Estrada S; Arikan F; Biagetti B
    Endocrinol Diabetes Metab Case Rep; 2019 Jul; 2019(1):. PubMed ID: 31310082
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stubborn hiccups as a sign of massive apoplexy in a naive acromegaly patient with pituitary macroadenoma.
    Simsek Bagir G; Civi S; Kardes O; Kayaselcuk F; Ertorer ME
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28567295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.